Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands: Clinical and Economic Effects

by Lisa A. de Jong, Judith J. Gout-Zwart, Jelena Stevanovic, Harrie Rila, Mike Koops, Menno V. Huisman, Maarten J. Postma
Published 2018-07-01

Cost-effectiveness of apixaban compared to other anticoagulants in patients with atrial fibrillation in the real-world and trial settings.

by Lisa A de Jong, Jessie Groeneveld, Jelena Stevanovic, Harrie Rila, Robert G Tieleman, Menno V Huisman, Maarten J Postma, Marinus van Hulst
Published 2019-01-01